- Home
- Publications
- Publication Search
- Publication Details
Title
Osteoblast-Osteoclast Communication and Bone Homeostasis
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 9, Pages 2073
Publisher
MDPI AG
Online
2020-09-11
DOI
10.3390/cells9092073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women with Osteoporosis: 5‐year Data from the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension
- (2020) Robert Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases
- (2020) Lingxin Zhu et al. Science Translational Medicine
- Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms
- (2019) Natalie A. Sims et al. Annual Review of Physiology
- Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
- (2018) Jinhu Xiong et al. Nature Communications
- Coupling of bone resorption and formation by RANKL reverse signalling
- (2018) Yuki Ikebuchi et al. NATURE
- Discovery of a periosteal stem cell mediating intramembranous bone formation
- (2018) Shawon Debnath et al. NATURE
- Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
- (2017) Matthew T Drake et al. ENDOCRINE REVIEWS
- Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro
- (2017) Harry C. Blair et al. TISSUE ENGINEERING PART B-REVIEWS
- Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification
- (2016) Stephen Tonna et al. DEVELOPMENT
- Merck & Co. drops osteoporosis drug odanacatib
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Osteocytic signalling pathways as therapeutic targets for bone fragility
- (2016) Lilian I. Plotkin et al. Nature Reviews Endocrinology
- Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
- (2016) Bente Langdahl et al. Therapeutic Advances in Musculoskeletal Disease
- Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass
- (2015) L Wang et al. CELL DEATH AND DIFFERENTIATION
- Parathyroid hormone: anabolic and catabolic actions on the skeleton
- (2015) Barbara C Silva et al. CURRENT OPINION IN PHARMACOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
- (2015) Faryal Mirza et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
- (2015) Boris Hinz MATRIX BIOLOGY
- EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis
- (2014) Stephen Tonna et al. FASEB JOURNAL
- Osteoclast-Derived Complement Component 3a Stimulates Osteoblast Differentiation
- (2014) Kazuhiko Matsuoka et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
- (2014) Sofia Movérare-Skrtic et al. NATURE MEDICINE
- Osteoclasts: more than ‘bone eaters’
- (2014) Julia F. Charles et al. TRENDS IN MOLECULAR MEDICINE
- Semaphorin 3A
- (2014) Ren Xu Cell Adhesion & Migration
- Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
- (2014) Natalie A. Sims et al. Current Osteoporosis Reports
- Understanding Coupling between Bone Resorption and Formation
- (2013) Thomas L. Andersen et al. AMERICAN JOURNAL OF PATHOLOGY
- Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
- (2013) Sutada Lotinun et al. JOURNAL OF CLINICAL INVESTIGATION
- Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation
- (2013) Sunao Takeshita et al. JOURNAL OF CLINICAL INVESTIGATION
- Sema3A regulates bone-mass accrual through sensory innervations
- (2013) Toru Fukuda et al. NATURE
- Clinical targeting of the TNF and TNFR superfamilies
- (2013) Michael Croft et al. NATURE REVIEWS DRUG DISCOVERY
- Osteopetrosis: genetics, treatment and new insights into osteoclast function
- (2013) Cristina Sobacchi et al. Nature Reviews Endocrinology
- Osteoclasts: New Insights
- (2013) Feng Xu et al. Bone Research
- Meta-analysis of genome-wide studies identifiesWNT16andESR1SNPs associated with bone mineral density in premenopausal women
- (2012) Daniel L Koller et al. JOURNAL OF BONE AND MINERAL RESEARCH
- EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone
- (2012) Farzin M Takyar et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoprotection by semaphorin 3A
- (2012) Mikihito Hayashi et al. NATURE
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
- (2012) Karol Estrada et al. NATURE GENETICS
- Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
- (2012) Lingling Xian et al. NATURE MEDICINE
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- Estrogen and the skeleton
- (2012) Sundeep Khosla et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus
- (2012) Carolina Medina-Gomez et al. PLoS Genetics
- Disorders of Bone Remodeling
- (2011) Xu Feng et al. Annual Review of Pathology-Mechanisms of Disease
- Bone remodelling at a glance
- (2011) J. C. Crockett et al. JOURNAL OF CELL SCIENCE
- Targeting osteoclast-osteoblast communication
- (2011) Xu Cao NATURE MEDICINE
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Suppression of bone formation by osteoclastic expression of semaphorin 4D
- (2011) Takako Negishi-Koga et al. NATURE MEDICINE
- Building strong bones: molecular regulation of the osteoblast lineage
- (2011) Fanxin Long NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
- (2011) Aline G. Costa et al. Nature Reviews Rheumatology
- Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011
- (2011) Yang Xue et al. Orphanet Journal of Rare Diseases
- Genetic Control of Bone Formation
- (2009) Gerard Karsenty et al. Annual Review of Cell and Developmental Biology
- Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
- (2009) Masaru Ishii et al. NATURE
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
- (2009) Yi Tang et al. NATURE MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Normal Bone Anatomy and Physiology
- (2008) B. Clarke Clinical Journal of the American Society of Nephrology
- Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival
- (2008) Susan A Krum et al. EMBO JOURNAL
- Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
- (2008) Charles A. O'Brien et al. PLoS One
- Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- (2008) L. Pederson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started